Why are patients with malignant lymphomas excluded from clinical trials? The experience of an Oncology Institute in Italy [1]

D. Serraino, V. Zagonel, R. Bordonaro, S. Franceschi

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
Pages (from-to)427-428
Number of pages2
JournalEuropean Journal of Cancer
Issue number3
Publication statusPublished - Feb 1998

ASJC Scopus subject areas

  • Cancer Research
  • Hematology
  • Oncology

Cite this